首页    期刊浏览 2025年02月26日 星期三
登录注册

文章基本信息

  • 标题:Cross talk of the first-line defense TLRs with PI3K/Akt pathway, in preconditioning therapeutic approach
  • 作者:Fatemeh Pourrajab ; Mohammad Baghi Yazdi ; Mojtaba Babaei Zarch
  • 期刊名称:Molecular and Cellular Therapies
  • 印刷版ISSN:2052-8426
  • 出版年度:2015
  • 卷号:3
  • 期号:1
  • 语种:English
  • 出版社:BioMed Central
  • 其他摘要:Toll-like receptor family (TLRs), pattern recognition receptors, is expressed not only on immune cells but also on non-immune cells, including cardiomyocytes, fibroblasts, and vascular endothelial cells. One main function of TLRs in the non-immune system is to regulate apoptosis. TLRs are the central mediators in hepatic, pulmonary, brain, and renal ischemic/reperfusion (I/R) injury. Up-regulation of TLRs and their ligation by either exogenous or endogenous danger signals plays critical roles in ischemia/reperfusion–induced tissue damage. Conventional TLR-NF-κB pathways are markedly activated in failing and ischemic myocardium. Recent studies have identified a cross talk between TLR activation and the PI3K/Akt pathway. The activation of TLRs is proposed to be the most potent preconditioning method after ischemia, to improve the cell survival via the mechanism involved the PI3K/Akt signaling pathway and to attenuate the subsequent TLR-NF-κB pathway stimulation. Thus, TLRs could be a great target in the new treatment approaches for myocardial I/R injury.
  • 关键词:TLRs; PI3K/AKT; Signaling; Cross talk
Loading...
联系我们|关于我们|网站声明
国家哲学社会科学文献中心版权所有